Skip to main content
TipRanks
Go Ultimate75% OFF

BioAge Labs, Inc. (BIOA) Stock Statistics & Valuation Metrics

160 Followers

Total Valuation

BioAge Labs, Inc. has a market cap or net worth of $255.07M. The enterprise value is $44.61M.

Market Cap
$255.07M
Enterprise Value
$44.61M

Share Statistics

BioAge Labs, Inc. has 45,958,508 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
45,958,508
Owned by Insiders
9.24%
Owned by Institutions
32.80%

Financial Efficiency

BioAge Labs, Inc.’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -33.38%.

Return on Equity (ROE)
-0.30
Return on Assets (ROA)
-0.27
Return on Invested Capital (ROIC)
-33.38%
Return on Capital Employed (ROCE)
-0.34
Revenue Per Employee
147.46K
Profits Per Employee
-1.32M
Employee Count
61
Asset Turnover
0.03
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of BioAge Labs, Inc. is -2.18. BioAge Labs, Inc.’s PEG ratio is 0.12.

PE Ratio
-2.18
PS Ratio
24.30
PB Ratio
0.74
Price to FCF
-2.03
Price to Operating Cash Flow
-2.49
PEG Ratio
0.12

Income Statement

In the last 12 months, BioAge Labs, Inc. had revenue of 8.99M and earned -80.61M in profits. Earnings per share was -2.24.

Revenue
8.99M
Gross Profit
8.99M
Operating Income
-92.78M
Pretax Income
-80.61M
Net Income
-80.61M
EBITDA
-79.69M
Earnings Per Share (EPS)
-2.24

Cash Flow

In the last 12 months, operating cash flow was -102.52M and capital expenditures -484,000, giving a free cash flow of -103.00M billion.

Operating Cash Flow
-102.52M
Free Cash Flow
-103.00M
Free Cash Flow per Share
-2.24

Dividends & Yields

BioAge Labs, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-49.29%
Earnings Yield
-42.31%

Stock Price Statistics

Beta
1.85
52-Week Price Change
-28.11%
50-Day Moving Average
6.60
200-Day Moving Average
15.08
Relative Strength Index (RSI)
41.92
Average Volume (3m)
733.47K

Important Dates

BioAge Labs, Inc. upcoming earnings date is Mar 25, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Mar 25, 2027
Ex-Dividend Date
―

Financial Position

BioAge Labs, Inc. as a current ratio of 14.24, with Debt / Equity ratio of 2.04%

Current Ratio
14.24
Quick Ratio
14.24
Debt to Market Cap
0.01
Net Debt to EBITDA
2.30
Interest Coverage Ratio
-133.11

Taxes

In the past 12 months, BioAge Labs, Inc. has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

BioAge Labs, Inc. EV to EBITDA ratio is -1.48, with an EV/FCF ratio of -1.54.

EV to Sales
18.49
EV to EBITDA
-1.48
EV to Free Cash Flow
-1.54
EV to Operating Cash Flow
-1.55

Balance Sheet

BioAge Labs, Inc. has $283.64M in cash and marketable securities with $2.73M in debt, giving a net cash position of $280.91M billion.

Cash & Marketable Securities
$283.64M
Total Debt
$2.73M
Net Cash
$280.91M
Net Cash Per Share
$6.11
Tangible Book Value Per Share
$7.55

Margins

Gross margin is 99.27%, with operating margin of -1401.81%, and net profit margin of -1253.60%.

Gross Margin
99.27%
Operating Margin
-1401.81%
Pretax Margin
-1253.60%
Net Profit Margin
-1253.60%
EBITDA Margin
-1248.78%
EBIT Margin
-1252.06%

Analyst Forecast

The average price target for BioAge Labs, Inc. is $22.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$22.25
Price Target Upside
300.90% Upside
Analyst Consensus
Strong Buy
Analyst Count
4
Revenue Growth Forecast
45.33%
EPS Growth Forecast
-20.81%

Scores

Smart Score
2
AI Score
45